Ryan Savitz - EVP, CFO & CBO at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Evp, Cfo & Cbo
Issuer Symbol
DNTH on Nasdaq
All Insider Reports
All Insider Reports

Ryan Savitz - trading volume in the past year for Dianthus Therapeutics, Inc. /DE/

Holdings reported by Ryan Savitz for Dianthus Therapeutics, Inc. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $45.18 04 Dec 2025 Direct
Stock Option (Right to Buy) 150,000 03 Feb 2026 Direct Common Stock

Transactions reported by Ryan Savitz for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.